99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2013

Conditions
Prostate Cancer
Interventions
DRUG

99mTc-MIP-1404

Trial Locations (1)

10065

New York Presbyterian Hospital, Weill Cornell Medical College, New York

All Listed Sponsors
lead

Molecular Insight Pharmaceuticals, Inc.

INDUSTRY

NCT01654874 - 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404 | Biotech Hunter | Biotech Hunter